The approval of pediatric COVID vaccines during the height of the pandemic brought reassurance to many parents and pediatricians who were caring for children with severe infections and, sometimes, Multi-system Inflammatory Syndrome in Children (MISC)—a rare but extremely dangerous condition that could impact even the healthiest kids after a COVID infection. But what’s the picture of pediatric COVID vaccination now? In this episode: a discussion about the risks and benefits of pediatric COVID vaccination in 2025.
Dr. Erica Prochaska is a pediatric infectious disease physician at Johns Hopkins School of Medicine.
Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland’s Health Department.
New FDA framework on Covid vaccines leaves pediatricians confused and concerned—STAT News
A Pediatric Cardiologist on What We Know—And Don’t Know—About COVID-19-Related Multi-System Inflammatory Syndrome in Children—Public Health On Call (June 2020)
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Here's our RSS feed
Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
